AMMAN - One Hundred COVID-19 deaths and 6,005 virus cases were recorded in the Kingdom on Tuesday, increasing the caseload to 645,449, the government announced.

The new fatalities took the Kingdom’s coronavirus death toll to 7,383 according to a joint statement issued by the Prime Ministry and the Ministry of Health.

The share of tests returning a positive result, known as positive rate, stood at nearly 13.62 per cent, compared with 15.12 per cent reported on Monday.

A total of 44,086 virus tests were also conducted on Tuesday, bringing the cumulative number of coronavirus tests administered since the outbreak of the pandemic to 6,158,68, according to the statement.

The statement added that 9,130 recoveries were registered in hospitals and home quarantine on Tuesday, bringing the total number of recoveries to 561,894.

The statement added that there are currently 76,172 active COVID-19 cases in Jordan.

A total of 347 COVID-19 patients were admitted to hospitals on Tuesday, taking the number of patients currently receiving care for COVID-19 in hospitals to 3,059, the statement said, adding that 361 recovered patients left hospitals.

On hospital capacities, the statement revealed that in the northern region the occupancy rate of isolation beds occupied by COVID-19 patients reached 49 per cent, ICU beds reached 77 per cent, while occupancy rate of ventilators stood at 52 per cent.

In the central region, isolation bed occupancy rate reached 59 per cent, 74 per cent for ICUs and 42 per cent for ventilators.

The statement added that the southern region registered an isolation bed occupancy rate of 32 per cent, 41 per cent for ICUs and 23 per cent for ventilators.

The cases comprised 2,269 infections in Amman, 942 in Irbid, including 942 in Ramtha District, 830 in Zarqa, 375 in Balqa, 306 in Mafraq, 251 in Karak, 243 in Madaba, 204 in Ajloun, 181 in Aqaba, 171 in Jerash, 153 in Tafileh, 80 in Maan, including four in Petra District.

© Copyright The Jordan Times. All rights reserved. Provided by SyndiGate Media Inc. (Syndigate.info).

Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.